Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

354.36
Delayed Data
As of Jan 23
 -8.20 / -2.26%
Today’s Change
325.35
Today|||52-Week Range
482.27
-3.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues1.1B1.2B1.2B1.2B
 
 
 
 
 
Cost of Goods Sold110.8M111.8M69.0M44.2M
 
 
 
 
 
Depreciation And Amortization22.9M23.0M25.0M27.8M
 
 
 
 
 
 
Operating ExpensesGross Income964.3M1.1B1.1B1.1B
 
 
 
 
 
General Expenses733.3M736.8M826.9M785.3M
 
 
 
 
 
Research And Development438.3M447.1M534.9M515.2M
 
 
 
 
 
Total Operating Expenses867.0M871.5M921.0M857.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income231.1M329.3M291.6M362.8M
 
 
 
 
 
Extraordinary Charge-1.9M0.000.000.00
 
 
Interest Expense On Debt3.6M1.4M2.2M222.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income227.3M330.2M292.3M365.9M
 
 
 
 
 
Income Taxes-72.3M-164.4M-96.0M-101.1M
 
 
 
 
 
Net Income155.0M165.7M196.2M264.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS103.8M104.3M104.6M104.8M
 
 
 
 
 
Shares To Calculate EPS Diluted115.5M114.2M116.2M116.5M
 
 
 
 
 
 
Earnings Per ShareEPS$1.34$1.45$1.69$2.27
 
 
 
 
 
EPS Diluted$1.34$1.45$1.69$2.27